These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 10225286)
1. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. Hormozi K; Parton R; Coote J FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286 [TBL] [Abstract][Full Text] [Related]
2. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations. Hormozi K; Parton R; Coote J Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788 [TBL] [Abstract][Full Text] [Related]
3. Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins. Westrop G; Hormozi K; da Costa N; Parton R; Coote J J Bacteriol; 1997 Feb; 179(3):871-9. PubMed ID: 9006045 [TBL] [Abstract][Full Text] [Related]
4. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Orr B; Douce G; Baillie S; Parton R; Coote J Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566 [TBL] [Abstract][Full Text] [Related]
6. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827 [TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro. Westrop GD; Hormozi EK; Da Costa NA; Parton R; Coote JG Gene; 1996 Nov; 180(1-2):91-9. PubMed ID: 8973351 [TBL] [Abstract][Full Text] [Related]
8. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals. Khosravani A; Parker MC; Parton R; Coote J Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242 [TBL] [Abstract][Full Text] [Related]
9. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196 [TBL] [Abstract][Full Text] [Related]
10. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate. Lim A; Ng JK; Locht C; Alonso S Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230 [TBL] [Abstract][Full Text] [Related]
11. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Sebo P; Glaser P; Sakamoto H; Ullmann A Gene; 1991 Jul; 104(1):19-24. PubMed ID: 1916273 [TBL] [Abstract][Full Text] [Related]
12. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458 [TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Lee SJ; Gray MC; Guo L; Sebo P; Hewlett EL Infect Immun; 1999 May; 67(5):2090-5. PubMed ID: 10225859 [TBL] [Abstract][Full Text] [Related]
14. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Gross MK; Au DC; Smith AL; Storm DR Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera. Arciniega JL; Hewlett EL; Edwards KM; Burns DL FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896 [TBL] [Abstract][Full Text] [Related]
16. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. Boyd AP; Ross PJ; Conroy H; Mahon N; Lavelle EC; Mills KH J Immunol; 2005 Jul; 175(2):730-8. PubMed ID: 16002668 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis. Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322 [TBL] [Abstract][Full Text] [Related]
18. Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. Benz R; Maier E; Ladant D; Ullmann A; Sebo P J Biol Chem; 1994 Nov; 269(44):27231-9. PubMed ID: 7525549 [TBL] [Abstract][Full Text] [Related]
19. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Iwaki M; Ullmann A; Sebo P Mol Microbiol; 1995 Sep; 17(6):1015-24. PubMed ID: 8594322 [TBL] [Abstract][Full Text] [Related]
20. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]